Axonal loss influences the response to rituximab treatment in neuropathy associated with IgM monoclonal gammopathy with anti-myelin-associated glycoprotein antibody. (2015)
Attributed to:
MICA: MRC Centre for Neuromuscular Diseases
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.jns.2014.11.006
PubMed Identifier: 25467141
Publication URI: http://europepmc.org/abstract/MED/25467141
Type: Journal Article/Review
Volume: 348
Parent Publication: Journal of the neurological sciences
Issue: 1-2
ISSN: 0022-510X